A prospective clinical study examining complementary neurorehabilitation added to standard care for an acute immune-mediated peripheral neuropathy and short-term outcomes.
Key Takeaways
- Prospective study enrolled 128 Guillain–Barré syndrome patients allocated to two groups
- At two weeks, complementary treatment achieved 53.45% versus 35.71% improvement in Hughes scores
- Adjusted analysis showed higher odds of MRC improvement with complementary therapy, adjusted OR 3.165